Overview
Nplex Biosciences develops proteomics tools using nanotechnology, including the nELISA platform for high-throughput protein measurement. The platform uses DNA nanotechnology to identify proteins on micron-sized beads, enabling miniaturized, highly parallel immunoassays. It differentiates itself by combining DNA-based protein identification with bead-based assays and a scalable, cost-efficient workflow that lowers the cost of antibody-based proteomics. Its goal is to provide a reliable, scalable proteomics platform that supports drug discovery, biomarker discovery, and personalized medicine.
Work here?Claim your company
About Nomic
Industries
Company Size
51-200
Company Stage
Series B
Total Funding
$60.1M
Headquarters
Montreal, Canada
Founded
2017
Get referred to Nomic
See people who can refer or advise you
Simplify's Take
What believers are saying
- Nomic and Broad Clinical Labs target broader commercialization starting in early 2027.
- June 2026 Sanger and HESI OASIS collaborations expand high-value dataset generation.
- September 2024's $42 million Series B lifted total funding above $60 million.
What critics are saying
- Illumina bought SomaLogic in January 2026, strengthening a much larger proteomics rival.
- Olink and SomaLogic already own distribution, squeezing Nomic's pricing and sales cycles.
- If pharma adoption stalls before 2027, Nomic stays a niche services business.
What makes Nomic unique
- nELISA delivers 99.99% specificity and 0.1 pg/mL sensitivity at 1,000-plus samples daily.
- Omni 1000 packages 1,000 curated assays with absolute quantification for discovery workflows.
- Nature Methods publication and Nomic Portal datasets validate scalable protein profiling workflows.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$60.1M
Above
Industry Average
Funded Over
4 Rounds
Industry standards
Benefits
Flexible Work Hours
Growth & Insights and Company News
6 month growth
-1%1 year growth
0%2 year growth
4%MONTREAL, September 17, 2024--Nomic Bio ("Nomic"), the Protein Profiling company, today announces the completion of an oversubscribed $42 million Series B funding round. The fresh capital will enable Nomic to accelerate the expansion of its commercial operations, further invest in advancing its state-of-the-art protein profiling platform, and broaden its transformative offerings to meet growing demand.
This week, Y Combinator (YC) held its Winter 2020 Demo Day, the 30th for the Silicon Valley incubator. To minimize health concerns during the COVID-19 outbreak, YC opted to host the demo day online. For this cohort, 16 Canadian startups participated.
Y Combinator’s Demo Day was a bit different this time around.
Nomic is Hiring for 6 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Nomic
Industries
Company Size
51-200
Company Stage
Series B
Total Funding
$60.1M
Headquarters
Montreal, Canada
Founded
2017
Nomic is Hiring for 6 Jobs on Simplify!
Find jobs on Simplify and start your career today